Romidepsin Treatment in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: A Systematic Review and Meta-Analysis : American Journal of Therapeutics

Secondary Logo

Journal Logo

Advanced Search
Letters to the Editor

Romidepsin Treatment in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: A Systematic Review and Meta-Analysis

Abdulsattar, Waleed MD1; Beran, Azizullah MD1; Alqahtani, Ali MD2; Abuhelwa, Ziad MD1; Mhanna, Mohammed MD1; Alloghbi, Abdurahman MD3; Srour, Omar MD1; Ayesh, Hazem MD1; Hamouda, Danae MD4

Author Information

1Department of Internal Medicine, University of Toledo, Toledo, OH

2Department of Hematology and Oncology, Georgetown University, Washington, DC

3Hematology and Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, MI

4Department of Hematology and Oncology, University of Toledo, Toledo, OH

There are no conflicts of interest to disclose.

American Journal of Therapeutics 29(5):p e589-e592, September/October 2022. | DOI: 10.1097/MJT.0000000000001419
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Full Text Access for Subscribers:

Not a Subscriber?

Buy
Request Permissions

You can read the full text of this article if you:

Access through Ovid